$KPTI Karyopharm Therapeutics Inc. Insider Trading Week 28/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Karyopharm Therapeutics Inc. in week 28/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 4.75 | 4,242 | 20,158 | 476,061 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 5,757 | 1,520 | 0 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.03 | 1 | 0 | 0 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 18.27 | 10,000 | 182,686 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 4.75 | 4,242 | 20,158 | 522,143 | 517.9 K to 522.1 K (+0.82 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 5,757 | 1,520 | 517,901 | 512.1 K to 517.9 K (+1.12 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.03 | 1 | 0 | 512,144 | 512.1 K to 512.1 K (0.00 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 4.75 | 4,242 | 20,158 | 476,061 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 5,757 | 1,520 | 0 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.03 | 1 | 0 | 0 | |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 18.27 | 10,000 | 182,686 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 4.75 | 4,242 | 20,158 | 522,143 | 517.9 K to 522.1 K (+0.82 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 5,757 | 1,520 | 517,901 | 512.1 K to 517.9 K (+1.12 %) |
Jul 20 2018 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.03 | 1 | 0 | 512,144 | 512.1 K to 512.1 K (0.00 %) |
Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.53 | 30,000 | 556,005 | 8,499,920 | 8.5 M to 8.5 M (-0.35 %) |
Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.50 | 17,346 | 320,901 | 8,529,920 | 8.5 M to 8.5 M (-0.20 %) |
Jul 18 2018 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 18.52 | 2,654 | 49,161 | 8,547,266 | 8.5 M to 8.5 M (-0.03 %) |